Approval · Notice of Compliance 36398 · 2025
BEXACAT: Notice of Compliance 36398
Issued November 19, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36398
- Date
- November 19, 2025
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BEXACAT | 02562936 | Marketed |
Medicinal ingredients
- BEXAGLIFLOZIN 15 MG per TAB